Dr. Deng joins Viracta from Kura Oncology, Inc. and Wellspring Biosciences, where he was Senior Director, Head of CMC. Dr. Deng led the CMC function – including development, manufacture, quality control, and clinical supply – of multiple programs through various phases of development (I, II and III and registrational). Prior to Kura, Dr. Deng spent thirteen years at Janssen Pharmaceutical Companies of Johnson & Johnson in various roles of increasing responsibility associated with process chemistry R&D, CRO management, and project management of discovery/preclinical development. He has more than 30 peer-reviewed journal publications, a book chapter and 14 issued patents to his credit. Dr. Deng holds a Ph.D. in organic chemistry from Emory University and MS and BS in chemistry from Fudan University.